Early Intervention to Protect the Mother-Child Relationship After

Status Recruiting

Clinical Trial Summary

Postpartum depression (PPD) may impair the mother-infant relationship and lead to both short and long-term suboptimal development of the baby. This study aims to evaluate the effectiveness of a targeted intervention (HUGS: Happiness Understanding Giving and Sharing) for enhancing the mother-infant relationship.

Clinical Trial Description

Post-partum depression (PPD) is the most common psychological pathology following childbirth and affects 12% of women in France. This pathology may impair the mother-infant relationship and lead to suboptimal development of the baby in the short and long-term. The prevalence of early interaction disorders is estimated at 73% among women suffering from PPD. Although treatments for PDD are effective, the mother-infant interaction remains impaired, as well as the short, medium and long-term development of the child. It is therefore essential to develop at a very early stage an intervention specifically targeting the mother-infant interaction, and to integrate this care into the general care given to mothers suffering from PPD. A short cognitive-behavioural therapy intervention focused on improving the quality of the mother-infant relationship (the HUGS program: Happiness, Understanding, Giving and Sharing) has been created and validated by Prof. Jeannette Milgrom's Australian team. The objective of our study is to evaluate the effectiveness of the HUGS programme compared to a Playtime control group using a randomised controlled trial in a population of women suffering from PPD and being cared for in 7 French maternity hospitals. The comparison will be made 6 months after intervention initiation using "Factor 1: Mother Positive Affective Involvement and Verbalization" of the PCERA (Parent-Child Early Relational Assessment) mother-child interaction evaluation scale. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05209789
Study type	Interventional
Source	University Hospital, Toulouse
Contact	Carole GENTILLEAU, MD
Phone	33-5 61 77 13 15
Email	gentilleau.c@chu-toulouse.fr
Status	Recruiting
Phase	N/A
Start date	December 18, 2023
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03665038` - A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)	Phase 3
Recruiting	`NCT06042972` - Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines
Completed	`NCT04813341` - Effectiveness of Mat Pilates and Aerobic Training on Fatigue and Depression	N/A
Terminated	`NCT04998565` - Add-on Effectiveness of EA or TENS in Early Postpartum Breast Engorgement	N/A
Completed	`NCT04135612` - The Impact of a Daily Smartphone-based Communication Among Postpartum Women on Breastfeeding Rates	N/A
Recruiting	`NCT05595486` - Baby2Home (B2H) Mobile Health Application	N/A
Not yet recruiting	`NCT04516668` - Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression
Completed	`NCT05215028` - Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study
Recruiting	`NCT04129476` - Effect of a Cooperative Education Program Based on Precede-Proceed Model During Pregnancy on Postpartum Depression	N/A
Recruiting	`NCT04193462` - Relationship-Based Intervention for Post-Partum Depression	N/A
Completed	`NCT03638687` - Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers
Active, not recruiting	`NCT03052374` - Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS")	N/A
Active, not recruiting	`NCT04940585` - ROSE in Sunset Park	N/A
Terminated	`NCT04011592` - Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression	Phase 2
Recruiting	`NCT05887115` - Nurse Family Partnership for Women With Previous Live Births	N/A
Completed	`NCT04818047` - Adaptation and Pilot Testing of Web and Mobile Interface for the VID-KIDS Intervention	N/A
Not yet recruiting	`NCT05643898` - "Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women	N/A
Terminated	`NCT04264520` - Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women	N/A
Recruiting	`NCT04845347` - A Wearable Morning Light Treatment for Postpartum Depression	N/A
Enrolling by invitation	`NCT05186272` - mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression — HUGS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms